B A PHARMACEUTICAL COMPOSITION FOR ANTI-CORONA VIRUS COMPRISING HEPATITIS B VIRUS-DERIVED POLYPEPTIDE
The present invention relates to a pharmaceutical composition for anti-coronavirus comprising a hepatitis B virus-derived polypeptide. Specifically, the polypeptide is a polypeptide consisting of the amino acid sequence of SEQ ID NO: 1, has no cytotoxicity, has an anti-coronavirus effect, can also e...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Korean |
Published |
07.07.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a pharmaceutical composition for anti-coronavirus comprising a hepatitis B virus-derived polypeptide. Specifically, the polypeptide is a polypeptide consisting of the amino acid sequence of SEQ ID NO: 1, has no cytotoxicity, has an anti-coronavirus effect, can also exhibit an anti-inflammatory effect, and exhibits a synergistic effect with existing coronavirus therapeutics, thereby being able to contribute to global public health.
B형 간염 바이러스 유래 폴리펩티드를 포함하는 항 코로나 바이러스용 약학적 조성물에 관한 것이다. 구체적으로 상기 폴리펩티드는 서열번호 1의 아미노산 서열로 이루어진 폴리펩티드로서, 세포 독성 없이, 항 코로나 바이러스 효과를 가지며, 항염증 효과도 나타낼 수 있으며, 기존의 코로나 바이러스 치료제와 시너지 효과를 나타내는 바, 세계 공중보건에 이바지할 수 있다. |
---|---|
Bibliography: | Application Number: KR20200188375 |